Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Reexamination Certificate
2007-06-26
2007-06-26
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
C554S035000, C554S042000, C554S062000, C554S085000, C554S110000
Reexamination Certificate
active
10659091
ABSTRACT:
The invention relates to the use of cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy as therapeutic agents e.g. as ocular hypotensives. The compounds used in accordance with the invention are represented by the following formula I:wherein a wavy segments indicate either the alpha (α) or beta (β) configuration; the dashed bond represents a double bond or a single bond; U, Y, X, R1, Ar, n, x and y are as defined in the specification.
REFERENCES:
patent: 4599353 (1986-07-01), Bito
patent: 4994274 (1991-02-01), Chan et al.
patent: 5028624 (1991-07-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
patent: 5152435 (1992-10-01), Stand et al.
patent: 5446041 (1995-08-01), Chan et al.
patent: 6160013 (2000-12-01), Selliah
patent: 6291522 (2001-09-01), Burk
patent: WO02/26704 (2001-08-01), None
patent: WO03/047513 (2003-06-01), None
Silverman, R. “The Organic Chemistry of Drug Design and Drug Action” (1992) Published by Academic Press, pp. 19-23.
Bito, L.Z.,Biological Protection with Prostaglandins, “Prostaglandins and Related Compounds as Potential Ocular Therapeutic Agents”, vol. 1, Chapter 18, 1985, pp. 231-252.
Bito, L.Z.,Glaucoma, Applied Pharmacology in the Medical Treatment, “Prostaglandins, Other Eicosanoids, and Their Derivatives as Potential Antiglaucoma Agents”,1984, Chapter 20, pp. 477-505.
Nilsson et al, Invest. Ophthalmol. Vis. Sci. (suppl), 284 (1987), Arvo Abstracts 9-6:00.
Bito, L.Z., Arch. Ophthalmol. “Prostaglandins” “Old Concepts and New Perspectives”, vol. 105, pp. 1036-1039 (1987).
Siebold et al, Prodrug 5 3, “Esterified protaglandin shows ‘potent’ promise”,1989.
Burk Robert M.
Old David W.
Allergan Inc.
Jiang Shaojia Anna
Johnson Brent A.
Olson Eric S.
Voet Martin A.
LandOfFree
Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3818497